JP2009530392A - タンパク質プレニルトランスフェラーゼの阻害剤 - Google Patents

タンパク質プレニルトランスフェラーゼの阻害剤 Download PDF

Info

Publication number
JP2009530392A
JP2009530392A JP2009501558A JP2009501558A JP2009530392A JP 2009530392 A JP2009530392 A JP 2009530392A JP 2009501558 A JP2009501558 A JP 2009501558A JP 2009501558 A JP2009501558 A JP 2009501558A JP 2009530392 A JP2009530392 A JP 2009530392A
Authority
JP
Japan
Prior art keywords
compound
cancer
compounds
salt
ggtase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009501558A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009530392A5 (https=
Inventor
冬彦 玉野井
オヒュン クウォン
渡辺　　勝
ハンナ フィジー
Original Assignee
ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア filed Critical ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア
Publication of JP2009530392A publication Critical patent/JP2009530392A/ja
Publication of JP2009530392A5 publication Critical patent/JP2009530392A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2009501558A 2006-03-22 2007-03-22 タンパク質プレニルトランスフェラーゼの阻害剤 Pending JP2009530392A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78444306P 2006-03-22 2006-03-22
PCT/US2007/007135 WO2007111948A2 (en) 2006-03-22 2007-03-22 Inhibitors of protein prenyltransferases

Publications (2)

Publication Number Publication Date
JP2009530392A true JP2009530392A (ja) 2009-08-27
JP2009530392A5 JP2009530392A5 (https=) 2010-05-20

Family

ID=38541651

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009501558A Pending JP2009530392A (ja) 2006-03-22 2007-03-22 タンパク質プレニルトランスフェラーゼの阻害剤

Country Status (7)

Country Link
US (1) US8093274B2 (https=)
EP (1) EP2007383A4 (https=)
JP (1) JP2009530392A (https=)
CN (1) CN101431996A (https=)
AU (1) AU2007229457A1 (https=)
CA (1) CA2647038A1 (https=)
WO (1) WO2007111948A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015519308A (ja) * 2012-04-10 2015-07-09 ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア 癌治療用組成物および方法

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US20030129724A1 (en) 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
US8999289B2 (en) 2005-03-22 2015-04-07 President And Fellows Of Harvard College Treatment of protein degradation disorders
US8222423B2 (en) 2006-02-14 2012-07-17 Dana-Farber Cancer Institute, Inc. Bifunctional histone deacetylase inhibitors
EP2007383A4 (en) 2006-03-22 2010-09-15 Univ California HEMMER OF PROTEIN PRENYL TRANSFERASES
US8304451B2 (en) * 2006-05-03 2012-11-06 President And Fellows Of Harvard College Histone deacetylase and tubulin deacetylase inhibitors
AU2009274549B2 (en) 2008-07-23 2014-05-01 Dana-Farber Cancer Institute, Inc. Deacetylase inhibitors and uses thereof
US20110178138A1 (en) * 2008-07-28 2011-07-21 The Regents Of The University Of California Inhibitors of protein prenyltransferases
US9125821B2 (en) 2008-07-28 2015-09-08 The Regents Of The University Of California Nanodrug targeting protein geranylgeranylation
WO2011019393A2 (en) 2009-08-11 2011-02-17 President And Fellows Of Harvard College Class- and isoform-specific hdac inhibitors and uses thereof
WO2012097371A2 (en) * 2011-01-14 2012-07-19 The Regents Of The University Of California Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis
EP2678680A4 (en) * 2011-02-24 2014-07-23 Univ California SMALL MOLECULES FOR ENDOTHELIAL CELL ACTIVATION
MX393973B (es) * 2011-05-08 2025-03-24 Legochem Biosciences Inc Conjugados de proteína-agente activo y método para su preparación.
KR20200066690A (ko) 2017-10-16 2020-06-10 칭화대학교 메발로네이트 경로 억제제 및 이의 약제학적 조성물
CN112574041B (zh) * 2020-12-25 2022-10-28 温州大学新材料与产业技术研究院 一种手性β羟基1,3-二羰基类化合物的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
WO2004015130A2 (en) 2002-08-07 2004-02-19 Exelixis Modulators of rabggt and methods of use thereof
BRPI0410630A (pt) * 2003-06-19 2006-06-13 Pfizer Prod Inc antagonista de nk1
EP2007383A4 (en) 2006-03-22 2010-09-15 Univ California HEMMER OF PROTEIN PRENYL TRANSFERASES

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JPN6012048689; Ｊｏｕｒｎａｌ　ｏｆ　Ｏｒｇａｎｉｃ　Ｃｈｅｍｉｓｔｒｙ Ｖｏｌ．７０，　Ｎｏ．２４, 2005, ｐ．９９７５-９９８４ *
JPN6012048691; Ｊｏｕｒｎａｌ　ｏｆ　ｔｈｅ　Ａｍｅｒｉｃａｎ　Ｃｈｅｍｉｃａｌ　Ｓｏｃｉｅｔｙ Ｖｏｌ．１２７，　Ｎｏ．３５, 2005, ｐ．１２２３４-１２２３５ *
JPN6012048694; Ｔｅｔｒａｈｅｄｒｏｎ Ｖｏｌ．６１，　Ｎｏ．２６, 2005, ｐ．６２７６-６２８２ *
JPN6012048696; Ｊｏｕｒｎａｌ　ｏｆ　ｔｈｅ　Ａｍｅｒｉｃａｎ　Ｃｈｅｍｉｃａｌ　Ｓｏｃｉｅｔｙ Ｖｏｌ．１２５，　Ｎｏ．１６, 2003, ｐ．４７１６-４７１７ *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015519308A (ja) * 2012-04-10 2015-07-09 ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア 癌治療用組成物および方法

Also Published As

Publication number Publication date
CN101431996A (zh) 2009-05-13
CA2647038A1 (en) 2007-10-04
US20100063114A1 (en) 2010-03-11
WO2007111948A2 (en) 2007-10-04
EP2007383A2 (en) 2008-12-31
WO2007111948A3 (en) 2008-08-07
AU2007229457A1 (en) 2007-10-04
US8093274B2 (en) 2012-01-10
EP2007383A4 (en) 2010-09-15

Similar Documents

Publication Publication Date Title
JP2009530392A (ja) タンパク質プレニルトランスフェラーゼの阻害剤
US8815935B2 (en) Inhibitors of protein prenyltransferases
Gerry et al. Chemical probes and drug leads from advances in synthetic planning and methodology
Kidd et al. Recent applications of diversity-oriented synthesis toward novel, 3-dimensional fragment collections
Battilocchio et al. A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity
von Nussbaum et al. Freezing the bioactive conformation to boost potency: The identification of BAY 85‐8501, a Selective and Potent Inhibitor of Human Neutrophil Elastase for Pulmonary Diseases
EA010652B1 (ru) Замещенные индолильные алкиламинопроизводные в качестве новых ингибиторов гистондеацетилазы
Shrivastava et al. Design, synthesis and evaluation of some N-methylenebenzenamine derivatives as selective acetylcholinesterase (AChE) inhibitor and antioxidant to enhance learning and memory
Perrone et al. Diarylheterocycle core ring features effect in selective COX‐1 inhibition
Tan et al. Synthesis of mimics of pramanicin from pyroglutamic acid and their antibacterial activity
Rodriquez et al. Total synthesis, NMR solution structure, and binding model of the potent histone deacetylase inhibitor FR235222
Akbarzadeh et al. The Pseudo‐Natural Product Rhonin Targets RHOGDI
Gagare et al. Natural product-inspired strategies towards the discovery of novel bioactive molecules
Alkubaisi et al. Complexity‐To‐Diversity and Pseudo‐Natural Product Strategies as Powerful Platforms for Deciphering Next‐Generation Therapeutics
Bacalhau et al. In silico, NMR and pharmacological evaluation of an hydroxyoxindole cholinesterase inhibitor
Jaiswal et al. Discovery of Isatin‐Based Carbohydrazones as Potential Dual Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase
Cateni et al. Synthesis of 4-thiophen-2′-yl-1, 4-dihydropyridines as potentiators of the CFTR chloride channel
Dincel et al. Discovery of Dual‐Inhibitor Acyl Hydrazones for Acetylcholinesterase and Carbonic Anhydrase I/II: A Mechanistic Insight into Alzheimer's Disease
Schwalen et al. Ube2n: hope on the cancer front, how to inhibit this promising target prospect?
Corredor et al. Efficient synthesis of conformationally restricted apoptosis inhibitors bearing a triazole moiety
Elumalai et al. Development of potent cholinesterase inhibitors based on a marine pharmacophore
Drewes Future strategies in epigenetic drug discovery
Krishna et al. Recent advances in computer-assisted structure-based identification and design of histone deacetylases inhibitors
Kalliokoski et al. Discovery of sulfonamides and 9-oxo-2, 8-diazaspiro [5, 5] undecane-2-carboxamides as human kynurenine aminotransferase 2 (KAT2) inhibitors
Sbardella Histone acetyltransferases: targets and inhibitors

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100310

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100310

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120919

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130304